Trial intelligence / Profile preview

Phase III open-label single-arm study of simeprevir with peginterferon alfa-2a and ribavirin in chronic hepatitis C genotype 4

2011-004097-29Phase 3Completed

Sponsor

Janssen Pharmaceutical

Start

Nov 2011

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1